MGTX (MeiraGTx Holdings) Prakiraan volume dodolan

Simbol lan logo merek MeiraGTx Corp (MGTX)

Sales dynamics expectations for MeiraGTx Holdings plc (MGTX), which brings together leading virologists to create gene vectors, show a value of 0.40, representing the current metric level. MeiraGTx Holdings plc (MGTX) is implementing advanced DNA correction methods to combat rare pathologies. Growth potential is supported by a lack of saturation in the ophthalmology drug niche and strategic partnerships with industry behemoths.

Volume dodolan sing dikarepake perusahaan: MeiraGTx Holdings plc (MGTX) kanggo 04.07.2022 - 18.11.2026

MeiraGTx PLC (MGTX) - rincian metrik lan laporan keuangan

- rega saiki lan proyeksi nilai saham:
Analisis dhasar perusahaan:MGTX MeiraGTx PLC
Produk merek MeiraGTx Holdings

The long-term reliability of MeiraGTx Holdings plc (MGTX) is determined by the stability of future cash flows, which are assessed via the estimated revenue growth rate based on current operational activity. Analyzing the company's sales forecast model on GURU.Markets, an investor can see business expansion dynamics supported by the diversification of gene platforms and in-house manufacturing, which minimizes external risks and confirms the company's sustainable growth.

Karo sapa MeiraGTx Holdings plc saingan

Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Dodolan mangsa ngarep perusahaan Qiagen Group|Prakiraan pendapatan perusahaan Ionis Pharma IONS|RGEN - Volume dodolan mangsa ngarep perusahaan|RNA - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CRSP (CRISPR Therapeutics AG)|Sema4 (WGS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan RARE (Ultragenyx)|Volume dodolan mangsa ngarep perusahaan BEAM|Prakiraan volume dodolan Sarepta Corp|Prakiraan pendapatan perusahaan Twist Bioscience, Inc. (TWST)|Volume dodolan mangsa ngarep perusahaan 10x Genomics TXG|Prakiraan pendapatan perusahaan Intellia Therapeutics NTLA|Prakiraan volume pendapatan perusahaan STOK (Stoke Therapeutics, Inc.)|BLFS - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Wave Pharma|mazetx.com (MAZE) - Prakiraan pendapatan perusahaan|SION - Dodolan mangsa ngarep perusahaan|PRME (Prime Medicine Inc) - Prakiraan volume dodolan|Taysha Gene Therapies, Inc. - Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan QURE|REGENXBIO Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Solid Biosciences SLDB|OCGN - Volume dodolan mangsa ngarep perusahaan|pacb.com - Prakiraan volume dodolan|Benitec (BNTC) - Volume dodolan mangsa ngarep perusahaan|DSGN: Prakiraan volume dodolan|RCKT - Dodolan mangsa ngarep perusahaan|FDMT: Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan LXEO (lexeotx.com)|Prakiraan pendapatan perusahaan Korro Bio Inc. (KRRO)|Prakiraan volume pendapatan perusahaan EDIT|Prakiraan volume dodolan SLN (Silence Therapeutics PLC)|Pendapatan mangsa ngarep perusahaan PRQR|CDXS - Prakiraan pendapatan perusahaan|SGMO (Sangamo Therapeutics) - Prakiraan pendapatan perusahaan|NAUT: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan MGX|DTIL (precisionbiosciences.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GBIO (Generation Bio Co.)|Prakiraan pendapatan perusahaan Boundless Bio (BOLD)|Exicure - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IMNN (imunon.com)|Dodolan mangsa ngarep perusahaan Phio Pharmaceuticals (PHIO)|MBIO: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Prakiraan pendapatan perusahaan|APDN - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BLUE|Prakiraan volume dodolan immunoprecise.com|Prakiraan volume dodolan OMGA|Dodolan mangsa ngarep perusahaan Singular Genomics Corp|Regulus Therapeutics - Volume dodolan mangsa ngarep perusahaan|SYRS (Syros Pharmaceuticals) - Pendapatan sing dikarepake perusahaan|Telesis Bio Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan TCON (TRACON Pharmaceuticals Inc.)|UBX: Prakiraan volume dodolan